2,761 reports of this reaction
2.4% of all OCTREOTIDE ACETATE reports
#7 most reported adverse reaction
NEEDLE ISSUE is the #7 most commonly reported adverse reaction for OCTREOTIDE ACETATE, manufactured by Novartis Pharmaceuticals Corporation. There are 2,761 FDA adverse event reports linking OCTREOTIDE ACETATE to NEEDLE ISSUE. This represents approximately 2.4% of all 115,420 adverse event reports for this drug.
OCTREOTIDE ACETATE has an overall safety score of 85 out of 100. Patients taking OCTREOTIDE ACETATE who experience needle issue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NEEDLE ISSUE is a less commonly reported adverse event for OCTREOTIDE ACETATE, but still significant enough to appear in the safety profile.
In addition to needle issue, the following adverse reactions have been reported for OCTREOTIDE ACETATE:
The following drugs have also been linked to needle issue in FDA adverse event reports:
NEEDLE ISSUE has been reported as an adverse event in 2,761 FDA reports for OCTREOTIDE ACETATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
NEEDLE ISSUE accounts for approximately 2.4% of all adverse event reports for OCTREOTIDE ACETATE, making it a notable side effect.
If you experience needle issue while taking OCTREOTIDE ACETATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.